Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis

Lorenza Caregaro(University of Padua), Angelo Gatta(University of Padua), Piero Amodio(University of Padua), Mario Plebani(University of Padua), Massimo Bolognesi(University of Padua), F. Alberino(University of Padua), Carlo Merkel(University of Padua), Paolo Angeli(European Association for the Study of Diabetes)
Nutrition
March 1, 1997
10.1016/s0899-9007(96)00399-1
Cited by 75

Related Papers

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
|Journal of Hepatology|2018|2.8k
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
|Hepatology|2014|2k
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
|Journal of Hepatology|2015|864
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference
|JAMA Network Open|2020|644
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites
|Gut|2015|576